Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3577446 | 0.79 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3HRH1 | |
| SCHEMBL8969997 | 0.76 | GBA1 (0.47) | SLC6A2SLC6A4SLC6A3HRH1DPP4 | |
| SCHEMBL8693765 | 0.74 | KDM4E (0.46) | HRH1 | |
| SCHEMBL27526570 | 0.74 | GBA1 (0.45) | SLC6A2SLC6A4SLC6A3DPP4 | |
| SCHEMBL4773880 | 0.73 | LMNA (0.40) | — | |
| SCHEMBL1334281 | 0.72 | ITGB3 (0.51) | SLC6A2SLC6A4SLC6A3HRH1 | |
| SCHEMBL27478385 | 0.72 | DPP4 (0.51) | SLC6A2SLC6A4SLC6A3HRH1TAAR1 | |
| SCHEMBL12735820 | 0.71 | ITGB3 (0.57) | SLC6A2SLC6A4SLC6A3HRH1KCNA3 | |
| Hydrochloric Acid SCHEMBL14691030 | 0.71 | ITGB3 (0.50) | SLC6A2SLC6A4SLC6A3HRH1 | |
| SCHEMBL3580578 | 0.70 | TACR1 (0.46) | SLC6A2SLC6A4SLC6A3HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | SLC6A2 735/4885SLC6A4 151/4885SLC6A3 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.